Padmini Jayaraman - Concepedia

Author

Padmini Jayaraman

Icahn School of Medicine at Mount Sinai

Also Known As

Jayaraman, Padmini, P. Kunthala Jayaraman, Padmini Jayaraman

Publications

997

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Baylor College of Medicine The University of Texas MD Anderson Cancer Center National Institute of Allergy and Infectious Diseases University of South Dakota

About

Padmini Jayaraman is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	298
2	Cell Biology	3	3	282
3	Immunology	3	3	194
4	Allergy	1	1	16
5	Autoimmune Disease	1	1	22

Padmini Jayaraman

Publications

987

Citations

H-Index

Page 1

	Year	Citations
Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization Geming Lu, Ruihua Zhang, Shuo Geng, Nature Communications	2015	216
Tumor-Expressed Inducible Nitric Oxide Synthase Controls Induction of Functional Myeloid-Derived Suppressor Cells through Modulation of Vascular Endothelial Growth Factor Release Padmini Jayaraman, Falguni Parikh, Esther López-Rivera, The Journal of Immunology ImmunologyImmunotherapyCancer BiologyTumor BiologyInflammation	2012	156
T cell–derived inducible nitric oxide synthase switches off TH17 cell differentiation Jianjun Yang, Ruihua Zhang, Geming Lu, The Journal of Experimental Medicine	2013	129
Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma <i>In vivo</i> and Synergizes with Chemotherapy Andrew G. Sikora, Alexander Gelbard, Michael A. Davies, Clinical Cancer Research	2010	120
Inducible Nitric Oxide Synthase Drives mTOR Pathway Activation and Proliferation of Human Melanoma by Reversible Nitrosylation of TSC2 Esther López-Rivera, Padmini Jayaraman, Falguni Parikh, Cancer Research Nitric OxideMtor Pathway ActivationPathway ActivationCancer BiologyTumor Biology	2014	104
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy Aurélie Hanoteau, Jared M. Newton, Rosemarie Krupar, Journal for ImmunoTherapy of Cancer	2019	84
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy Padmini Jayaraman, Falguni Parikh, Jared M. Newton, OncoImmunology	2018	63
iNOS Expression in CD4+ T Cells Limits Treg Induction by Repressing TGFβ1: Combined iNOS Inhibition and Treg Depletion Unmask Endogenous Antitumor Immunity Padmini Jayaraman, Matthew G. Alfarano, Peter F. Svider, Clinical Cancer Research	2014	55
Unrestrained Glycogen Synthase Kinase-3β Activity Leads to Activated T Cell Death and Can Be Inhibited by Natural Adjuvant Sadhak Sengupta, Padmini Jayaraman, Paula M. Chilton, The Journal of Immunology Adaptive Immune SystemT-regulatory CellApoptosisImmune RegulationImmunology	2007	22
Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy Michael Pan, Yichun Fu, Ellen H. de Moll, Cancer Immunology Research	2015	22

Page 1